PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 3680533

Collection and analysis of complex ELISA data using a microcomputer.

S M Ross·C P Reynolds
View original source ↗Export metadata ↓

Abstract

A system for automatic Enzyme-Linked Immunosorbent Assay (ELISA) data collection and processing is described. Hardware for the system consists of a Dynatech microplate reader and Apple II series microcomputer. Software developed by the authors allows automatic configuration of the reader and direct data input from the microplate reader to the microcomputer. After optical density data is input through the interface, it can be printed out as either optical density values, or as scaled values (from 0 to 9) in a color-coded matrix. Data can be stored and later recalled in either format, allowing several sets of data to be merged into one large, color-coded chart. Results from several different microplates can be combined and sorted in a single printout to expedite interpretation of data.

Explore related subjects

ComputersElectronic Data ProcessingEnzyme-Linked Immunosorbent AssayMicrocomputersJournal ArticleResearch Support, U.S. Gov't, Non-P.H.S.

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S M Ross, C P Reynolds. 1987. Collection and analysis of complex ELISA data using a microcomputer.. https://doi.org/10.1080/15321818708057031

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2000

Avatars in space.

Explore the source record for details and available documents.

Computers↗
PubMed2000

Structure-based inhibitor design.

Time and costs associated with the discovery of new drugs have been significantly reduced by enzyme structure-based approaches to the discovery of new chemotherapeutic agents. However, fundamental components of the overall approach continue to rely on technologies which, by their nature, involve relatively random processes (i.e., combinatorial chemistry and high-throughput screening). Thus, the efficiency of the drug discovery process potentially could be further improved through better use of structural information. In this regard, three-dimensional structures of enzymes are now being solved at high resolution and/or in conformations that provide data that should be more useful for inhibitor design or discovery. Scientists are beginning to appreciate the importance of water as a possible competitor of inhibitors for binding to target enzymes. New computational algorithms are improving the efficiency of identifying flexible inhibitors from among the large numbers of compounds in chemical databases. Also, tools of molecular genetics together with structures of target enzymes are likely to be used more frequently in dealing with the development of resistance to novel chemotherapeutic agents. Instead of detailing success stories in structure-based drug discovery, the following article considers how future efforts to discover or design new drugs may increasingly rely on information about molecular targets and less on data acquired via approaches involving random methodologies.

Computers↗